Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Tesetaxel |
Synonyms | |
Therapy Description |
Tesetaxel (DJ-927) is a taxane that stabilizes tubulin and inhibits microtubule disassembly, potentially resulting in increased cytotoxicity in tumor cells and decreased tumor growth (PMID: 12824894, PMID: 21547572). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Tesetaxel | DJ-927 | Antimicrotubule Agent 14 | Tesetaxel (DJ-927) is a taxane that stabilizes tubulin and inhibits microtubule disassembly, potentially resulting in increased cytotoxicity in tumor cells and decreased tumor growth (PMID: 12824894, PMID: 21547572). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03952325 | Phase II | Pembrolizumab + Tesetaxel Nivolumab + Tesetaxel Tesetaxel Atezolizumab + Tesetaxel | Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Metastatic TNBC and Tesetaxel Monotherapy in Patients With HER2 Negative MBC (CONTESSA TRIO) | Terminated | USA | 2 |